Impact of insight on treatment adherence in bipolar disorder

Introduction Extreme mood swings are a hallmark of bipolar disorder (BD). Consistent treatment adherence, including medication and regular attendance at outpatient care, is usually necessary for the effective management of BD. However, many individuals with BD struggle with treatment engagement, which is often influenced by several factors, including insight. Objectives This study aims to explore the relationship between patients’ level of insight into their condition and their attendance at scheduled treatments Methods It was a cross-sectional, descriptive, and analytical study conducted on bipolar disorder patients from the Psychiatry “A” Department, Hedi Chaker University Hospital. Clinical and sociodemographic data were collected from March to September 2023 using a questionnaire along with Medication Adherence Rating Scale (MARS) for assessing treatment adherence and the Birchwood Insight Scale (BIS) to evaluate insight Results A total of 37 patients with BD completed the questionnaire. The mean age was 45.4 ± 13.9 years, with a sex ratio (M/F) of 1.46. In our study, 73% of patients were with BD type I and 27% were with BD type II. The mean MARS score was 7.14 ± 2.13, and 37.8% of our population were non-adherent to medication. The mean BIS score was 8.58 ± 2.35, and 56.8% of patients had good insight. Mean scores of awareness of illness, re-labeling of symptoms, and need for treatment subscales of BIS were respectively 2.86, 2.73, and 2.86. The MARS score was positively correlated with the BIS score (p = 0.002, r = 0.40). The MARS score was also positively correlated with both the awareness of illness subscale of the BIS (p = 0.035, r = 0.34) and the re-labeling of symptoms subscale of the BIS (p = 0.41, r = 0.33). Conclusions This study demonstrates that certain aspects of insight are significantly associated with treatment adherence in bipolar disorder. Specifically, a wareness of illness and re-labeling of symptoms suggest that the ability to reinterpret and understand symptoms may enhance engagement with care. In contrast, the Need for Treatment subscale did not show a significant correlation with attendance, indicating that simply recognizing the need for treatment alone may not be sufficient to ensure consistent participation in care. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.1081
Primary Topic
Digital Mental Health Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of insight on treatment adherence in bipolar disorder

R. Masmoudi, J. Masmoudi, D. Mnif, F. Guermazi et al.
European Psychiatry
Digital Mental Health Interventions
article

Impact of insight on treatment adherence in bipolar disorder

R. Masmoudi, J. Masmoudi, D. Mnif, F. Guermazi, F. Sahnoun, I. Baati, I. Féki, F. Chérif
article en

Abstract

Introduction Extreme mood swings are a hallmark of bipolar disorder (BD). Consistent treatment adherence, including medication and regular attendance at outpatient care, is usually necessary for the effective management of BD. However, many individuals with BD struggle with treatment engagement, which is often influenced by several factors, including insight. Objectives This study aims to explore the relationship between patients’ level of insight into their condition and their attendance at scheduled treatments Methods It was a cross-sectional, descriptive, and analytical study conducted on bipolar disorder patients from the Psychiatry “A” Department, Hedi Chaker University Hospital. Clinical and sociodemographic data were collected from March to September 2023 using a questionnaire along with Medication Adherence Rating Scale (MARS) for assessing treatment adherence and the Birchwood Insight Scale (BIS) to evaluate insight Results A total of 37 patients with BD completed the questionnaire. The mean age was 45.4 ± 13.9 years, with a sex ratio (M/F) of 1.46. In our study, 73% of patients were with BD type I and 27% were with BD type II. The mean MARS score was 7.14 ± 2.13, and 37.8% of our population were non-adherent to medication. The mean BIS score was 8.58 ± 2.35, and 56.8% of patients had good insight. Mean scores of awareness of illness, re-labeling of symptoms, and need for treatment subscales of BIS were respectively 2.86, 2.73, and 2.86. The MARS score was positively correlated with the BIS score (p = 0.002, r = 0.40). The MARS score was also positively correlated with both the awareness of illness subscale of the BIS (p = 0.035, r = 0.34) and the re-labeling of symptoms subscale of the BIS (p = 0.41, r = 0.33). Conclusions This study demonstrates that certain aspects of insight are significantly associated with treatment adherence in bipolar disorder. Specifically, a wareness of illness and re-labeling of symptoms suggest that the ability to reinterpret and understand symptoms may enhance engagement with care. In contrast, the Need for Treatment subscale did not show a significant correlation with attendance, indicating that simply recognizing the need for treatment alone may not be sufficient to ensure consistent participation in care. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
Hopital Universitaire Hedi Chaker (TN)
Openalex Percentile: Top 73%
Digital Mental Health Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.